Inhibitory effect of phthalic acid on tyrosinase: The mixed-type inhibition and docking simulations

Enzyme Research

Volumn 2011, Issue 1, 2011, Pages

  Yin, Shang Jun ^a   Si, Yue Xiu ^a   Qian, Guo Ying ^a  

^a ZHEJIANG WANLI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LEUCINE; LEVODOPA; MONOPHENOL MONOOXYGENASE; PHTHALIC ACID;

ALGORITHM; ARTICLE; DRUG MECHANISM; DRUG SCREENING; ENZYME ACTIVE SITE; ENZYME ANALYSIS; ENZYME BINDING; ENZYME INHIBITION; ENZYME KINETICS; ENZYME STRUCTURE; HYPERPIGMENTATION; IC 50; MATHEMATICAL COMPUTING; MOLECULAR DOCKING; MOLECULAR MECHANICS; NUCLEOTIDE SEQUENCE; OXIDATION; PRIORITY JOURNAL;

RUMEX;

EID: 84868217197     PISSN: 20900406     EISSN: 20900414     Source Type: Journal    
DOI: 10.4061/2011/294724     Document Type: Article

References (34)

1. Olivares C., Solano F., New insights into the active site structure and catalytic mechanism of tyrosinase and its related proteins. Pigment Cell and Melanoma Research 2009 22 6 750 760 2-s2.0-70350102888 10.1111/j.1755-148X.2009. 00636.x
2. García-Molina F., Muoz J. L., Varón R., Rodríguez-López J. N., García-Cánovas F., Tudela J., A review on spectrophotometric methods for measuring the monophenolase and diphenolase activities of tyrosinase. Journal of Agricultural and Food Chemistry 2007 55 24 9739 9749 2-s2.0-37349053743 10.1021/jf0712301 (Pubitemid 350305154)
3. Jimbow K., Park J. S., Kato F., Hirosaki K., Toyofuku K., Hua C., Yamashita T., Assembly, target-signaling and intracellular transport of tyrosinase gene family proteins in the initial stage of melanosome biogenesis. Pigment Cell Research 2000 13 4 222 229 2-s2.0-0033854292 10.1034/j.1600-0749. 2000.130403.x (Pubitemid 30610798)
4. Hasegawa T., Treis A., Patenge N., Fiesel F. C., Springer W., Kahle P. J., Parkin protects against tyrosinase-mediated dopamine neurotoxicity by suppressing stress-activated protein kinase pathways. Journal of Neurochemistry 2008 105 5 1700 1715 2-s2.0-43549122572 10.1111/j.1471-4159.2008.05277.x (Pubitemid 351678502)
5. Boissy R. E., Manga P., On the etiology of contact/occupational vitiligo. Pigment Cell Research 2004 17 3 208 214 2-s2.0-2642539089 10.1111/j.1600-0749. 2004.00130.x (Pubitemid 38724550)
6. Nishioka E., Funasaka Y., Kondoh H., Chakraborty A. K., Mishima Y., Ichihashi M., Expression of tyrosinase, TRP-1 and TRP-2 in ultraviolet- irradiated human melanomas and melanocytes: TRP-2 protects melanoma cells from ultraviolet B induced apoptosis. Melanoma Research 1999 9 5 433 443 2-s2.0-0032697226 (Pubitemid 29494108)
7. Salopek T. G., Jimbow K., Induction of melanogenesis during the various melanoma growth phases and the role of tyrosinase, lysosome-associated membrane proteins, and p90 calnexin in the melanogenesis cascade. Journal of Investigative Dermatology Symposium Proceedings 1996 1 2 195 202 2-s2.0-0030112276 (Pubitemid 126759365)
8. Carrillo E., Prados J., Marchal J. A., Boulaiz H., Martínez A., Rodríguez-Serrano F., Caba O., Serrano S., Aránega A., Prognostic value of RT-PCR tyrosinase detection in peripheral blood of melanoma patients. Disease Markers 2006 22 3 175 181 2-s2.0-33745157867 (Pubitemid 43893796)
9. Mangas C., Hilari J. M., Paradelo C., Rex J., Fernández-Figueras M. T., Fraile M., Alastrue A., Ferrándiz C., Prognostic significance of molecular staging study of sentinel lymph nodes by reverse transcriptase- polymerase chain reaction for tyrosinase in melanoma patients. Annals of Surgical Oncology 2006 13 7 910 918 2-s2.0-33745237195 10.1245/ASO.2006.12.010
10. Tomita Y., Tyrosinase gene mutations causing oculocutaneous albinisms. Journal of Investigative Dermatology 1993 100 supplement 2 186S 190S 2-s2.0-0027417524 (Pubitemid 23051696)
11. Oetting W. S., The tyrosinase gene and oculocutaneous albinism type 1 (OCA1): a model for understanding the molecular biology of melanin formation. Pigment Cell Research 2000 13 5 320 325 2-s2.0-0033815395 10.1034/j.1600-0749. 2000.130503.x
12. Suzuki T., Tomita Y., Recent advances in genetic analyses of oculocutaneous albinism types 2 and 4. Journal of Dermatological Science 2008 51 1 1 9 2-s2.0-42749097427 10.1016/j.jdermsci.2007.12.008
13. Criton M., Le Mellay-Hamon V., veronique.lemellay-hamon@mayoly-spindler. fr Dimeric cinnamoylamide derivatives as inhibitors of melanogenesis. Biological and Pharmaceutical Bulletin 2011 34 3 420 425 10.1248/bpb.34.420
14. Wang H. M., davidw@kmu.edu.tw Chen C. Y., Wen Z. H., Identifying melanogenesis inhibitors from cinnamomum subavenium with in vitro and in vivo screening systems by targeting the human tyrosinase. Experimental Dermatology 2011 20 3 242 248 10.1111/j.1600-0625.2010.01161.x
15. Ando H., hideyaando@aol.com Matsui M. S., mmatsui@Estee.com Ichihashi M., mmichihashi@hotmail.com Quasi-drugs developed in Japan for the prevention or treatment of hyperpigmentary disorders. International Journal of Molecular Sciences 2010 11 6 2566 2575 10.3390/ijms11062566
16. Decker H., Tuczek F., Tyrosinase/catecholoxidase activity of hemocyanins: structural basis and molecular mechanism. Trends in Biochemical Sciences 2000 25 8 392 397 2-s2.0-0034255667 10.1016/S0968-0004(00)01602-9 (Pubitemid 30497251)
17. Gou L., Lü Z. R., Park D., Sang HO. O., Shi L., Seong J. P., Bhak J., Park Y. D., Ren Z. L., Zou F., The effect of histidine residue modification on tyrosinase activity and conformation: inhibition kinetics and computational prediction. Journal of Biomolecular Structure and Dynamics 2008 26 3 395 402 2-s2.0-57749179740
18. Lü Z. R., Shi L., Wang J., Park D., Bhak J., Yang J. M., Park Y. D., Zhou H. W., Zou F., The effect of trifluoroethanol on tyrosinase activity and conformation: inhibition kinetics and computational simulations. Applied Biochemistry and Biotechnology 2010 160 7 1896 1908 2-s2.0-77949914143 10.1007/s12010-009-8730-9
19. Shiino M., Watanabe Y., Umezawa K., Synthesis and tyrosinase inhibitory activity of novel N-hydroxybenzyl-N-nitrosohydroxylamines. Bioorganic Chemistry 2003 31 2 129 135 2-s2.0-0037394181 10.1016/S0045-2068(03)00026-9 (Pubitemid 36506835)
20. Kim D., Park J., Kim J., Han C., Yoon J., Kim N., Seo J., Lee C., Flavonoids as mushroom tyrosinase inhibitors: a fluorescence quenching study. Journal of Agricultural and Food Chemistry 2006 54 3 935 941 2-s2.0-33244460034 10.1021/jf0521855 (Pubitemid 43274134)
21. Kanade S. R., Suhas V. L., Chandra N., Gowda L. R., Functional interaction of diphenols with polyphenol oxidase. Molecular determinants of substrate/inhibitor specificity. FEBS Journal 2007 274 16 4177 4187 2-s2.0-34547758423 10.1111/j.1742-4658.2007.05944.x (Pubitemid 47228634)
22. Yan Q., Cao R., Yi W., Yu L., Chen Z., Ma L., Song H., Synthesis and evaluation of 5-benzylidene(thio)barbiturate- β -D-glycosides as mushroom tyrosinase inhibitors. Bioorganic and Medicinal Chemistry Letters 2009 19 15 4055 4058 2-s2.0-67649909586 10.1016/j.bmcl.2009.06.018
23. Park Y. D., Kim S. Y., Lyou Y. J., Lee J. Y., Yang J. M., A new type of uncompetitive inhibition of tyrosinase induced by Cl- binding. Biochimie 2005 87 11 931 937 2-s2.0-25444479368 10.1016/j.biochi.2005.06.006 (Pubitemid 41377152)
24. Han H. Y., Lee J. R., Xu W. A., Hahn M. J., Yang J. M., Park Y. D., Effect of Cl- on tyrosinase: complex inhibition kinetics and biochemical implication. Journal of Biomolecular Structure and Dynamics 2007 25 2 165 171 2-s2.0-34548835242
25. Xie M. X., Xu X. Y., Wang Y. D., Interaction between hesperetin and human serum albumin revealed by spectroscopic methods. Biochimica et Biophysica Acta 2005 1724 1-2 215 224 2-s2.0-20444413775 10.1016/j.bbagen.2005.04.009 (Pubitemid 40799127)
26. Arnold K., Bordoli L., Kopp J., Schwede T., Trsten.Schwede@unibas.ch The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 2006 22 2 195 201 10.1093/bioinformatics/bti770 (Pubitemid 43205406)
27. Morris G. M., Huey R., Lindstrom W., Sanner M. F., Belew R. K., Goodsell D. S., Olson A. J., AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry 2009 30 16 2785 2791 2-s2.0-70349932423 10.1002/jcc.21256
28. Huey R., Morris G. M., Olson A. J., Goodsell D. S., A semiempirical free energy force field with charge-based desolvation. Journal of Computational Chemistry 2007 28 6 1145 1152 2-s2.0-33947716119 10.1002/jcc.20634 (Pubitemid 46506716)
29. Muoz-Muoz J. L., Garcia-Molina F., Varon R., Garcia-Ruíz P. A., Tudela J., Garcia-Cánovas F., canovasf@um.es Rodríguez-Lopez J. N., Suicide inactivation of the diphenolase and monophenolase activities of tyrosinase. IUBMB Life 2010 62 7 539 547 10.1002/iub.348
30. Si Y. X., Yin S. J., Park D., Chung H. Y., Yan L., Lü Z. R., Zhou H. M., Yang J. M., Qian G. Y., qiangy@zwu.edu.cn Park Y.-D., parkyd@hotmail.com Tyrosinase inhibition by isophthalic acid: kinetics and computational simulation. International Journal of Biological Macromolecules 2011 48 4 700 704 10.1016/j.ijbiomac.2011.02.015
31. Khatib S., Nerya O., Musa R., Shmuel M., Tamir S., Vaya J., Chalcones as potent tyrosinase inhibitors: the importance of a 2,4-substituted resorcinol moiety. Bioorganic and Medicinal Chemistry 2005 13 2 433 441 2-s2.0-10444280081 10.1016/j.bmc.2004.10.010 (Pubitemid 39642925)
32. Gasowska B., Kafarski P., Wojtasek H., Interaction of mushroom tyrosinase with aromatic amines, o-diamines and o-aminophenols. Biochimica et Biophysica Acta 2004 1673 3 170 177 2-s2.0-3242811929 10.1016/j.bbagen.2004.04.013 (Pubitemid 38981770)
33. Park Y. D., Kim S. Y., Lyou Y. J., Lee D. Y., Yang J. M., TXM13 human melanoma cells: a novel source for the inhibition kinetics of human tyrosinase and for screening whitening agents. Biochemistry and Cell Biology 2006 84 1 112 116 2-s2.0-33645394824 10.1139/o05-151
34. Park Y. D., Lyou Y. J., Hahn H. S., Hahn M. J., Yang J. M., Complex inhibition of tyrosinase by thiol-composed Cu2+ chelators: a clue for designing whitening agents. Journal of Biomolecular Structure and Dynamics 2006 24 2 131 138 2-s2.0-33749989366